New CEO for Gold Terra: Gerald Panneton
Source: The Critical Investor  (12/28/21)
Although Gerald Panneton was already guiding Gold Terra as an Executive Chairman, it seems likely after this restructuring he will have full control being a Chairman and CEO effective January 1st, 2022. As he was used to be thinking big at Detour, the Critical Investor expects more of the same here. More >

Counting Down the Top Drill Holes of 2021
Source: Streetwise Reports  (12/28/21)
On any given business day, results from a drill hole can turn a Wednesday into Christmas Day for shareholders. We take a look at what experts think are the best drill holes of 2021. More >

Analyst Takes Year-End Stock of His Portfolio
Source: Adrian Day  (12/28/21)
In a year-end bulletin, Adrian Day gives a brief reminder of the fundamental reason for each stock in his portfolio, as well as to note the largest downside or risk for each. More >

Canadian Co. to Explore New Finnish Properties
Source: The Critical Investor  (12/28/21)
After a year of slow progress for Avrupa Minerals, management decided to create more opportunities by acquiring four exploration properties in Finland. More >

Why Invest in This Uranium Explorer Now
Source: Streetwise Reports  (12/27/21)
In the Dec. 22 episode of Streetwise Live!, influential uranium investor Terry Papineau tells why he believes now is the right time to invest in the uranium sector and, specifically, in Baselode Energy. Its CEO James Sykes discusses the company's new high-grade discovery and its work plan for 2022.

More >

Gold Mining to Commence at BC Project in Q1/22
  (12/27/21)
"The recovery of first gold from stage one of Omineca Mining and Metals' Wingdam placer project could be a major catalyst for the stock," noted a Research Capital report. More >

Silver Dollar Has Silver Eq at $.08 an Ounce
Source: Bob Moriarty  (12/26/21)
Bob Moriarty of 321Gold says that for astute investors, Silver Dollar Resources Inc. is a good bet into February regardless of what the rest of the market does. More >

Co. Rated Outperform As Heart Failure Drug Nears Potential Approval
  (12/25/21)
"Cytokinetics' pipeline of muscle-directed therapies has potential to address several diseases with high unmet medical need and may generate significant revenue across pipeline programs," noted an Oppenheimer report. More >

Analyst: Question Lingers Over Biotech’s Cell Therapy
  (12/23/21)
A DawsonJames report notes that Brainstorm Cell Therapeutics’ autologous stem cells in amyotrophic lateral sclerosis will need further study to prove their effectiveness.
More >

Coverage Initiated on Biopharma Co. After Turnaround Story
  (12/23/21)
"With Acasti Pharma shares trading near cash levels yet current resources sufficient to achieve key development milestones across the pipeline over 2022-2023, we recommend investors build a position," noted an Oppenheimer report.
More >

Coverage Initiated on Texas-Based Shrimp Farming Company
Source: Streetwise Reports  (12/23/21)
What differentiates NaturalShrimp is its proprietary technology that allows it to "produce recirculating aquaculture system-raised shrimp at a sufficient density for mass production," noted a ROTH Capital Partners report. More >

It's 'All Systems Go' for This Gold Co.
Source: Chris Temple  (12/23/21)
Chris Temple, editor and publisher of The National Investor, explains Omineca Mining & Metals' almost 50% increase and why his rationale for his initial recommendation of Omineca remains unchanged. More >

Nikola Shares Gain 18% After Bulk Transport Co. Signs LOI to Buy 100 Zero-Emission Trucks
Source: Streetwise Reports  (12/23/21)
Nikola Corp. shares traded higher after the firm reported that Heniff Transportation Systems LLC signed a letter of intent to purchase 100 zero-emission trucks from Thompson Truck Center and Nikola. More >

Wingdam Close to Panning in ‘One of the Richest Placer Deposits in British Columbia History’
Source: Streetwise Reports  (12/22/21)
Near Quesnel, B.C., a small Canadian company is about to take placer gold mining public. It’s been a long road, but it looks like British Columbia’s Cariboo region could see another gold rush more than 160 years after the first. More >

Renewable Energy Co. Plans to Expand Capacity to 30GW by 2025
  (12/21/21)
In a December 15 research note, H.C. Wainwright & Co. Equity Research Analysts Sameer Joshi and Amit Dayal commented that community and commercial solar power company UGE International Ltd. (UGE:TSX.V; UGEIF:OTCQB) is "positioned to capture value across the project lifecycle." More >

Market Expert Calls Uranium and Vanadium Company a Buy
Source: Michael Ballanger  (12/21/21)
Industry observer Michael Ballanger explains why he has Western Uranium and Vanadium Corp. on his buy list. More >

Leading Computer Memory and Storage Manufacturer Expects Record Revenue
Source: Streetwise Reports  (12/21/21)
Micron Technology Inc. shares traded 11% higher after the company reported Q1/22 financial results and stated that it was on a path toward record revenue and solid profitability in FY/22. More >

Analyst Highlights Top Picks in Biotech for 2022
  (12/20/21)
Aldeyra Therapeutics, in the ophthalmology space, and SQZ Biotechnologies, in the cell therapy sector, have "advantages that their specific approaches allow," noted a BTIG report. More >

Remembering Wharton: Detecting When the Fed Turns 'For or Against You'
Source: Michael Ballanger  (12/20/21)
Precious metals expert Michael Ballanger remembers lessons learned years ago from a three-year course in "Stocks and Bonds 101," and how those principles still apply today. More >

FDA Grants Approval for CNS-Focused Biopharma Firm's Bipolar Disorder Drug
Source: Streetwise Reports  (12/20/21)
Intra-Cellular Therapies Inc. shares traded 19% higher to a new 52-week high after the company reported the U.S. FDA has approved the use of its CAPLYTA® (lumateperone) for treatment of adults with bipolar depression. More >

Dolly Varden Silver: Consolidating a High-Grade Gold-Silver District In British Columbia
Source: The Critical Investor  (12/19/21)
After Dolly Varden Silver announced the transaction with Fury Gold Mines regarding the Homestake Ridge Project, the Critical Investor looked into future potential coming from combining Homestake with the Dolly Varden Project, and exploration potential. More >

Thoma Bravo Makes $2.6 Billion Offer to Take Bottomline Technologies Private
Source: Streetwise Reports  (12/18/21)
Shares of Bottomline Technologies Inc. traded 15% higher after the company reported it agreed to be acquired by private equity firm Thoma Bravo for $57.00 per share in cash. More >

Outlook Positive After Agricultural Firm Beats Expectations
Source: Streetwise Reports  (12/17/21)
Alico "offers a compelling opportunity" given expectations for increased production and pricing and continued dividends paid to shareholders, noted a ROTH Capital Partners report. More >

Investment Opportunity: Fast Growing Data Firm Helping Global Brands Retain Customers
Source: Streetwise Reports  (12/17/21)
In this Dec. 15 episode of Streetwise Live! viewers learned about Datable Technology, what it does, why it is a compelling story and why two former Disney executives invested in it. They, Mike Ridgewell and Marc Reintjes, were on the panel along with Datable Chairman Kim Oishi and eResearch analyst Chris Thompson. More >

Co. Launches Pivotal Phase in Alzheimer's Agitation Drug's Trial
  (12/17/21)
BioXcel Therapeutics' lead drug candidate for agitation in Alzheimer's disease patients could serve a substantial market, noted an H.C. Wainwright & Co. report. More >